Endocrinology and Diabetology Service – RT: Bone and parathyroid cross-talk

Endocrinology and Diabetology Service

Director: Dr. Sabrina Corbetta

Research Topics

Bone and parathyroid cross-talk

topic 2_and 3_descrip_diabetology_1000x733

The regulatory effect of PTH on bone is well established while biological active substances released from bone with a regulatory function on parathyroid cells are emerging. The crosstalk between bone and parathyroid cells occurs by means of the phosphaturic hormone FGF23, released from osteoblasts/osteocytes, and leptin, released from adipocytes and osteoblasts. Parathyroid cells express the specific receptor for FGF23, FGF receptor/a-Klotho complex, and for leptin. Here, we identified osteocalcin as a further hormone potentially involved in the crosstalk between bone and parathyroid cells, demonstrating that human parathyroid cells express the osteocalcin receptor GPRC6A and respond to stimulation with increasing concentrations of osteocalcin in term of modulation of the ERK and AKT pathways.